Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research.

@article{Keating2013AutologousBC,
  title={Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research.},
  author={Armand Keating and Gisela DaSilva and Waleska S. P{\'e}rez and Vikas Gupta and Corey S Cutler and Karen Kuhn Ballen and Mitchell S Cairo and Bruce M. Camitta and Richard E. Champlin and James L. Gajewski and Hillard M Lazarus and Michael C. Lill and David Ian Marks and Chadi Nabhan and Gary J. Schiller and Gerald Socie and Jeff Szer and Martin S. Tallman and Daniel J. Weisdorf},
  journal={Haematologica},
  year={2013},
  volume={98 2},
  pages={185-92}
}
The optimal post-remission treatment for acute myeloid leukemia in first complete remission remains uncertain. Previous comparisons of autologous versus allogeneic hematopoietic cell transplantation noted higher relapse, but lower treatment-related mortality though using bone marrow grafts, with treatment-related mortality of 12-20%. Recognizing lower… CONTINUE READING